Abstract
Aggressive behaviors can be classified into proactive and reactive functions, though there is disagreement about whether these are distinct constructs. Data suggest that proactive and reactive aggression have different etiologies, correlates, and response to treatment. Several rating scales are available to characterize aggressive behavior as proactive or reactive; one commonly used scale was originally developed for teacher ratings, referred to here as the Antisocial Behavior Scale (ABS). However, no data are available on the psychometric properties of the ABS for parent ratings. This study examined the factor structure and convergent/divergent validity of the parent-rated ABS among 168 children aged 6–12 years with attention-deficit hyperactivity disorder, a disruptive behavior disorder, and severe aggression enrolled in a randomized clinical trial. Multidimensional item response theory was used to confirm the original factor structure. The proactive and reactive factors were distinct but moderately correlated; the algorithm items exhibited acceptable fit on the original factors. The non-algorithm items caused theoretical problems and model misfit. Convergent and divergent validity of the scale was explored between the ABS and other parent-report measures. Proactive and reactive aggression showed differential correlates consistent with expectations for externalizing symptoms. The subscales were correlated weakly or not at all with most non-externalizing symptoms, with some exceptions. Thus, the original factor structure was supported and we found preliminary evidence for the validity of the scale, though the results suggest that the constructs measured by the ABS may not be totally distinct from general behavior problems in this clinical sample.
Similar content being viewed by others
References
Aman, M., Bukstein, O., Gadow, K., Arnold, L., Molina, B., McNamara, N., et al. (2014). What does risperidone add to stimulant and parent raining for severe aggression in child ADHD? Journal of the American Academy of Child and Adolescent Psychiatry, 53, 47–60.
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & The Risperidone Disruptive Behavior Study Group. (2002). Risperidone treatment of children with disruptive behavior disorders and subaverage IQ: A double-blind, placebo-controlled study. American Journal of Psychiatry, 159, 1337–1346.
Aman, M. G., Leone, S., Lecavalier, L., Park, L., Buican, B., & Coury, D. (2008). The Nisonger Child Behavior Rating Form—Typical IQ Version, for children with typical IQ. International Clinical Psychopharmacology, 23, 232–242.
Arsenio, W. F., Adams, E., & Gold, J. (2009). Social information processing, moral reasoning, and emotion attributions: Relations with adolescents’ reactive and proactive aggression. Child Development, 80, 1739–1755.
Brown, K., Atkins, M. S., Osborne, M. L., & Milnamow, M. (1996). A revised teacher rating scale for reactive and proactive aggression. Journal of Abnormal Child Psychology, 24, 473–480.
Browne, M. W., & Cudeck, R. (1992). Alternative ways of assessing model fit. Sociological Methods and Research, 21, 230–258.
Browne, M. W., Cudeck, R., Tateneni, K., & Mels, G. (2008). CEFA: Comprehensive exploratory factor analysis, version 3.03 [Computer software and manual]. Retrieved from http://faculty.psy.ohio-state.edu/browne/
Bushman, B. J., & Anderson, C. A. (2001). Is it time to pull the plub on the hostile versus instrumental aggression dichotomy? Psychological Review, 108, 273–279.
Cai, L., du Toit, S. H. C., & Thissen, D. (2011). IRTPro: Flexible, multidimensional, multiple categorical IRT modeling [Computer software]. Chicago, IL: Scientific Software International.
Cai, L., Maydeu-Olivares, A., Coffman, D. L., & Thissen, D. (2006). Limited information goodness-of-fit testing of item response theory models for sparse 2p tables. British Journal of Mathematical and Statistical Psychology, 59, 173–194.
Card, N. A., & Little, T. D. (2006). Proactive and reactive aggression in childhood and adolescence: A meta-analysis of differential relations with psychosocial adjustment. International Journal of Behavioral Development, 30, 466–480.
DeWall, C. N., Anderson, C. A., & Bushman, B. J. (2011). The general aggression model: Theoretical extensions to violence. Psychology of Violence, 1, 245–258.
Dodge, K. A. (1991). The structure and function of reactive and proactive aggression. In D. J. Pepler & K. H. Rubin (Eds.), The development and treatment of childhood aggression (pp. 201–218). Hillsdale, NJ: Lawrence Erlbaum Associates.
Dodge, K. A., & Coie, J. D. (1987). Social-information processing factors in reactive and proactive aggression in children’s peer groups. Journal of Personality and Social Psychology, 53, 1146–1158.
Epstein, N. B., Baldwin, L. M., & Bishop, D. S. (1983). The McMaster family assessment device. Journal of Marital and Family Therapy, 9, 171–180.
Farmer, C. A., Arnold, L. E., Bukstein, O. G., Findling, R. L., Gadow, K. D., Li, X., et al. (2011). The treatment of severe child aggression (TOSCA) study: Design challenges. Child and Adolescent Psychiatry and Mental Health, 5(36), 1–11. doi:10.1186/1753-2000-5-36.
Fite, P. J., Colder, C. R., Lochman, J. E., & Wells, K. C. (2008). Developmental trajectories of proactive and reactive aggression from fifth to ninth grade. Journal of Clinical Child and Adolescent Psychology, 37, 412–421.
Fite, P. J., Stoppelbein, L., & Greening, L. (2009). Proactive and reactive aggression in a child psychiatric inpatient population. Journal of Clinical Child and Adolescent Psychology, 38, 199–205.
Fossati, A., Borroni, S., Eisenberg, N., & Maffei, C. (2010). Relations of proactive and reactive dimensions of aggression to overt and covert narcissism in nonclinical adolescents. Aggressive Behavior, 36, 21–27.
Gadow, K. G., & Sprafkin, J. (2002). Child symptom inventory 4: Screening and norms manual. Stony Brook, NY: Checkmate Plus, LTD.
Hubbard, J. A., McAuliffe, M. D., Morrow, M. T., & Romano, L. J. (2010). Reactive and proactive aggression in childhood and adolescence: Precursors, outcomes, processes, experiences, and measurement. Journal of Personality, 78, 95–118.
Jensen, P. S., Youngstrom, E. A., Steiner, H., Findling, R. L., Meyer, R. E., Malone, R. P., et al. (2007). Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: Implications for medication studies. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 309–322.
Kalton, G., & Schuman, H. (1982). The effect of the question on survey responses: A review. Journal of the Royal Statistical Society Series A, 145, 42–73.
Kempes, M., Matthys, W., de Vries, H., & van Engeland, H. (2005). Reactive and proactive aggression in children: A review of theory, findings and the relevance for child and adolescent psychiatry. European Journal of Child and Adolescent Psychiatry, 14, 11–19.
Kempes, M., Matthys, W., Maassen, G., van Goozen, S., & van Engeland, H. (2006). A parent questionnaire for distinguishing between reactive and proactive aggression in children. European Journal of Child and Adolescent Psychiatry, 15, 38–45.
Little, T. D., Jones, S. M., Henrich, C. C., & Hawley, P. H. (2003). Disentangling the “whys” from the “whats” of aggressive behaviour. International Journal of Behavioral Development, 27, 122–133.
Malone, R. P., Bennett, D. S., Luebbert, J. F., Rowan, A. B., Biesecker, K. A., Blaney, B. L., & Delaney, M. A. (1997). Aggression classification and treatment response. Psychopharmacology Bulletin, 34(1), 41–45.
Marsee, M. A., Barry, C. T., Childs, K. K., Frick, P. J., Kimonis, E. R., Muñoz, L. C., et al. (2011). Assessing the forms and functions of aggression using self-report: Factor structure and invariance of the Peer Conflict Scale in youths. Psychological Assessment, 23, 792–804.
Marsee, M. A., & Frick, P. J. (2007). Exploring the cognitive and emotional correlates to proactive and reactive aggression in a sample of detained girls. Journal of Abnormal Child Psychology, 35(6), 969–981.
Miller-Johnson, S., Coie, J. D., Maumary-Gremaud, A., Bierman, K., & Conduct Problems Prevention Research Group. (2002). Peer rejection and aggression and early starter models of conduct disorder. Journal of Abnormal Child Psychology, 30, 217–230.
Ostrov, J. M., & Crick, N. R. (2007). Forms and functions of aggression during early childhood: A short-term longitudinal study. School Psychology Review, 36, 22–43.
Polman, H., de Castro, B. O., Koops, W., van Boxtel, H. W., & Merk, W. W. (2007). A meta-analysis of the distinction between reactive and proactive aggression in children and adolescents. Journal of Abnormal Child Psychology, 35, 522–535.
Poulin, F., & Boivin, M. (2000). Reactive and proactive aggression: Evidence of a two-factor model. Psychological Assessment, 12, 115–122.
Prinstein, M. J., & Cillessen, A. H. N. (2003). Forms and functions of adolescent peer aggression associated with high levels of peer status. Merrill-Palmer Quarterly, 49, 310–342.
Snyder, R., Turgay, A., Aman, M. G., Binder, C., Fisman, S., Carroll, A., & The Risperidone Conduct Study Group. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1026–1036.
Stanford, M. S., Houston, R. J., Mathias, C. W., Greve, K. W., Villemarette-Pittman, N. R., & Adams, D. (2001). A double-blind placebo-controlled crossover study phenytoin in individuals with impulsive aggression. Psychiatry Research, 103(2), 193–203.
van Prooijen, J.-W., & van der Kloot, W. A. (2001). Confirmatory analysis of exploratively obtained factor structures. Educational and Psychological Measurement, 61, 777–792.
Vitaro, F., Brendgen, M., & Barker, E. D. (2006). Subtypes of aggressive behaviors: A developmental perspective. International Journal of Behavioral Development, 30, 12–19.
Wirth, R. J., & Edwards, M. C. (2007). Item factor analysis: Current approaches and future directions. Psychological Methods, 12, 58–79.
Acknowledgments
This study was supported by grants from National Institute of Mental Health (NIMH) to The Ohio State University (R01 MH077907), Case Western Reserve University (R01 MH077750), the University of Pittsburgh (R01 MH077676), and Stony Brook University (R01 MH 077997). The project was supported by a National Institutes of Health (NIH) General Clinical Research Center grant M01RR10710 (State University of New York Stony Brook) and Clinical and Translational Science Awards from the National Center for Advancing Translational Sciences: grants 8UL1TR000090-05 (The Ohio State University) and UL1 RR024153 and UL1TR000005 (University of Pittsburgh). The content is solely the responsibility of the authors and does not necessarily represent the official views of the respective National Centers for Advancing Translational Sciences or the NIH.
Conflict of interest
Dr. Findling receives or has received research support, acted as a consultant and/or served on a speaker’s bureau for Alexza Pharmaceuticals, American Academy of Child & Adolescent Psychiatry, American Physician Institute, American Psychiatric Press, AstraZeneca, Bracket, Bristol-Myers Squibb, Clinsys, Cognition Group, Coronado Biosciences, Dana Foundation, Forest, GlaxoSmithKline, Guilford Press, Johns Hopkins University Press, Johnson & Johnson, KemPharm, Lilly, Lundbeck, Merck, NIH, Novartis, Noven, Otsuka, Oxford University Press, Pfizer, Physicians Postgraduate Press, Rhodes Pharmaceuticals, Roche, Sage, Seaside Pharmaceuticals, Shire, Stanley Medical Research Institute, Sunovion, Supernus Pharmaceuticals, Transcept Pharmaceuticals, Validus, and WebMD. Dr. Bukstein has received royalties from Routledge Press and acted as a consultant for Ezra Innovations and PRIME CME. Dr. Arnold has received research funding from CureMark, Forest, Eli Lilly and Co., and Shire; advisory board honoraria from Biomarin, Novartis, Noven, Roche, and Seaside Therapeutics; consulting fees from TrisPharma and Pfizer; and travel support from Noven. Dr. Bangalore has received research only support from Supernus Pharmaceuticals. Dr. McNamara has received research support from Forest Research, GlaxoSmithKline, Eli Lilly and Co., Lundbeck, Merck, the NIH, Novartis, Otsuka, Pfizer, Rhodes Pharmaceuticals, Roche, Shire, Stanley Medical Research Institute, Sunovion, and Supernus Pharmaceuticals. Dr. Aman has received research contracts, consulted with, or served on advisory boards of Biomarin Pharmaceuticals, Bristol-Myers Squibb, Cog State, Confluence Pharmaceutica, Coronado Biosciences, Forest Research, Hoffman LaRoche, Johnson and Johnson, MedAvante Inc., Novartis, Pfizer, ProPhase LLC, and Supernus Pharmaceuticals. Dr. Kaat, Dr. Farmer, and Dr. Gadow report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Farmer is now at the National Institute of Mental Health. Dr. Findling is now at Johns Hopkins University and the Kennedy Krieger Institute. Dr. Bukstein is now at DePelchin Children’s Center, the University of Texas, and the Baylor College of Medicine.
Rights and permissions
About this article
Cite this article
Kaat, A.J., Farmer, C.A., Gadow, K.D. et al. Factor Validity of a Proactive and Reactive Aggression Rating Scale. J Child Fam Stud 24, 2734–2744 (2015). https://doi.org/10.1007/s10826-014-0075-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10826-014-0075-5